| ISIN | IE00BD03RL98 |
|---|---|
| Valor Number | 47733415 |
| Bloomberg Global ID | EISEQSG ID |
| Fund Name | E.I. Sturdza Funds plc - Strategic Europe Quality Fund SI GBP H |
| Fund Provider |
E.I. Sturdza Strategic Management Limited
Phone: +44 1481 722322 E-Mail: info@ericsturdza.com Web: www.ericsturdza.com |
| Fund Provider | E.I. Sturdza Strategic Management Limited |
| Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
| Distributor(s) |
Eric Sturdza Asset Management SA Geneva |
| Asset Class | Equities |
| EFC Category | Equity Europe |
| Distribution Policy | Accumulation |
| Home Country | Ireland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the Fund is to achieve long term capital growth. |
| Peculiarities |
| Current Price * | 106.18 GBP | 16.01.2026 |
|---|---|---|
| Previous Price * | 106.66 GBP | 15.01.2026 |
| 52 Week High * | 106.66 GBP | 09.01.2026 |
| 52 Week Low * | 85.83 GBP | 07.04.2025 |
| NAV * | 106.18 GBP | 16.01.2026 |
| Issue Price * | ||
| Redemption Price * | 106.18 GBP | 16.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 81,446,244 | |
| Unit/Share Assets *** | 13,612 | |
| Trading Information SIX | ||
| YTD Performance | +2.62% |
31.12.2025 - 16.01.2026
31.12.2025 16.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +3.13% |
31.12.2025 - 16.01.2026
31.12.2025 16.01.2026 |
| 1 month | +4.18% |
16.12.2025 - 16.01.2026
16.12.2025 16.01.2026 |
| 3 months | +4.30% |
16.10.2025 - 16.01.2026
16.10.2025 16.01.2026 |
| 6 months | +7.09% |
16.07.2025 - 16.01.2026
16.07.2025 16.01.2026 |
| 1 year | +5.64% |
19.03.2025 - 16.01.2026
19.03.2025 16.01.2026 |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 4.69% | |
|---|---|---|
| Compagnie Financiere Richemont SA Class A | 4.46% | |
| Danone SA | 4.45% | |
| Bureau Veritas SA | 4.25% | |
| Essilorluxottica | 4.19% | |
| Rolls-Royce Holdings PLC | 4.01% | |
| ASML Holding NV | 3.76% | |
| Galderma Group AG Registered Shares | 3.20% | |
| Erste Group Bank AG. | 3.04% | |
| MTU Aero Engines AG | 3.01% | |
| Last data update | 31.12.2025 | |
| TER *** | 1.00% |
|---|---|
| TER date *** | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.75% |
| Ongoing Charges *** | 1.00% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |